Fate Therapeutics, Inc. (FATE) Profit Margins
Over the twelve months to 2026-06-30, Fate Therapeutics, Inc. (FATE) had operating margin -2058.1%, net margin -1941.1%, free cash flow margin -1627.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FATEFate Therapeutics, Inc.Follow FATE — free
—
Price chart with a free account
- Market cap
- 252.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 4 days
| Line | FY2013 Dec 13 | FY2015 Dec 15 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -1820.3% | -1142.8% | -1415.4% | -943.1% | -407.5% | -388.6% | -320.2% | -299.9% | -1542.6% | -2222.4% | -2058.1% | |
| Net margin | -2151.8% | -1233.7% | -1405.0% | -919.0% | -551.6% | -379.9% | -292.5% | -253.3% | -1366.5% | -2051.1% | -1941.1% | |
| FCF margin | -1608.3% | -818.4% | -864.0% | -848.0% | -140.5% | -382.4% | -294.7% | -217.9% | -906.8% | -1685.8% | -1627.2% |
USD millions · SEC XBRL
Fate Therapeutics, Inc. — questions
- What is Fate Therapeutics, Inc.'s operating margin?
- -2058.1% over the twelve months to 2026-06-30.
- What is Fate Therapeutics, Inc.'s net profit margin?
- -1941.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Fate Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.